Home › Mga Impeksyon sa Virus
Pag-aaral pangklinika para sa Mga Impeksyon sa Virus na nagre-recruit sa U.S.
31 pag-aaral para sa Mga Impeksyon sa Virus ang nagre-recruit ng mga kalahok sa mga site sa buong Estados Unidos.
Mga lungsod na may pinakamaraming pag-aaral
- Washington, DC12 pag-aaral
- Houston, TX6 pag-aaral
- Boston, MA6 pag-aaral
- Baltimore, MD5 pag-aaral
- Hialeah, FL5 pag-aaral
- Columbus, OH4 pag-aaral
- Dallas, TX4 pag-aaral
- Atlanta, GA4 pag-aaral
- Cincinnati, OH4 pag-aaral
- San Francisco, CA3 pag-aaral
- St. Louis, MO3 pag-aaral
- Omaha, NE3 pag-aaral
- Miami, FL3 pag-aaral
- Tampa, FL3 pag-aaral
- Boise, ID3 pag-aaral
- Los Angeles, CA3 pag-aaral
- Worcester, MA3 pag-aaral
- Durham, NC3 pag-aaral
- Salt Lake City, UT3 pag-aaral
- New York City, NY3 pag-aaral
Ayos sa estado
- Alabama3 pag-aaral
- California11 pag-aaral
- Colorado3 pag-aaral
- District of Columbia5 pag-aaral
- Florida6 pag-aaral
- Georgia5 pag-aaral
- Idaho3 pag-aaral
- Illinois3 pag-aaral
- Kentucky3 pag-aaral
- Louisiana3 pag-aaral
- Maryland14 pag-aaral
- Massachusetts6 pag-aaral
- Michigan3 pag-aaral
- Missouri4 pag-aaral
- Nebraska3 pag-aaral
- New York6 pag-aaral
- North Carolina5 pag-aaral
- Ohio9 pag-aaral
- Pennsylvania5 pag-aaral
- South Carolina3 pag-aaral
- Texas9 pag-aaral
- Utah4 pag-aaral
- Virginia4 pag-aaral
Mga pag-aaral na kamakailan lamang in-update
Opisyal na teksto ng pag-aaral (English)
Efficacy and Safety of Tozorakimab in Patients Hospitalised for Viral Lung Infection Requiring Supplemental Oxygen
Nagre-recruitPhase 3
Edad 18 pataas · Lahat ng kasarian · Na-update Okt 2, 2026 · NCT05624450A Study of S-337395 in Symptomatic Nonhospitalized Adults With Respiratory Syncytial Virus (RSV) Who Are at High Risk of Progression to Severe Disease
Nagre-recruitPhase 2
Edad 18 pataas · Lahat ng kasarian · Na-update Set 29, 2026 · NCT07214571Specimen Collections From Participants With HIV Infection, KSHV Infection, Viral-Related Pre-malignant Lesions and Cancer
Nagre-recruitObservasyonal na pag-aaral
Edad 18 hanggang 120 · Lahat ng kasarian · Na-update Set 28, 2026 · NCT00006518The Natural History of Severe Viral Infections and Characterization of Immune Defects in Patients Without Known Immunocompromise
Nagre-recruitObservasyonal na pag-aaral
Edad 2 hanggang 100 · Lahat ng kasarian · Na-update Set 28, 2026 · NCT01011712A Study of COVID-19 Vaccine(s) in Children and Adults
Nagre-recruitPhase 3Malugod na tinatanggap ang malusog na boluntaryo
Edad 5 pataas · Lahat ng kasarian · Na-update Set 28, 2026 · NCT07798648A Study to Learn About a Study Medicine Called Ibuzatrelvir in Adult and Adolescent Patients With COVID-19 Who Are Not Hospitalized But Are at Risk For Severe Disease
Nagre-recruitPhase 3
Edad 12 pataas · Lahat ng kasarian · Na-update Set 25, 2026 · NCT06679140A Study to Learn About the Study Medicine Ibuzatrelvir in Adults With COVID-19 Who Are Severely Immunocompromised
Nagre-recruitPhase 3
Edad 18 pataas · Lahat ng kasarian · Na-update Set 25, 2026 · NCT07013474Phase 1 Challenge Study Using rDEN2delta30-7169 to Evaluate Host-Pathogen Interactions in Primary, Homotypic, and Heterotypic Dengue Virus Infection
Nagre-recruitPhase 1Malugod na tinatanggap ang malusog na boluntaryo
Edad 18 hanggang 50 · Lahat ng kasarian · Na-update Set 25, 2026 · NCT07706686Study of AHB-137 in Chronic Hepatitis B (CHB) Participants in North America and Europe Regions
Nagre-recruitPhase 2
Edad 18 hanggang 65 · Lahat ng kasarian · Na-update Set 24, 2026 · NCT07654283A Clinical Study to Investigate the Safety and Immunogenicity of rVSV∆G-SUDV-GP, a Sudan Virus (SUDV) Vaccine for the Prevention of SUDV Disease in Adults in Good General Health
Nagre-recruitPhase 1Malugod na tinatanggap ang malusog na boluntaryo
Edad 18 hanggang 50 · Lahat ng kasarian · Na-update Set 21, 2026 · NCT07565090Evaluating the Dose, Safety, Tolerability, and Immunogenicity of Mosaic Hexavalent Influenza Vaccine VRCFLUMOS0116-00-VP (FluMos-v2) With and Without ALFQ Adjuvant in Healthy Adults
Nagre-recruitPhase 1Malugod na tinatanggap ang malusog na boluntaryo
Edad 18 hanggang 50 · Lahat ng kasarian · Na-update Set 15, 2026 · NCT06863142Viral Infections in Healthy and Immunocompromised Hosts
Nagre-recruitObservasyonal na pag-aaralMalugod na tinatanggap ang malusog na boluntaryo
6 Months – 120 Years · Lahat ng kasarian · Na-update Set 14, 2026 · NCT01306084Acute Infection in Mitochondrial Disease: Metabolism, Infection and Immunity
Nagre-recruitObservasyonal na pag-aaralMalugod na tinatanggap ang malusog na boluntaryo
2 Months – 115 Years · Lahat ng kasarian · Na-update Set 10, 2026 · NCT04419870HSV G207 in Children With Recurrent or Refractory Cerebellar Brain Tumors
Nagre-recruitPhase 1
36 Months – 22 Years · Lahat ng kasarian · Na-update Set 4, 2026 · NCT03911388Trial of Scheduled Versus Treatment Administration of Donor-Derived Viral Specific T-cells for Viral Infections After Stem Cell Transplant
Nagre-recruitPhase 2
Lahat ng edad · Lahat ng kasarian · Na-update Set 4, 2026 · NCT04230356Donor-Derived Viral Specific T-cells (VSTs)
Nagre-recruitPhase 1/2
4 Weeks · Lahat ng kasarian · Na-update Set 4, 2026 · NCT02048332Third Party Viral Specific T-cells (VSTs)
Nagre-recruitPhase 2
2 Days · Lahat ng kasarian · Na-update Set 4, 2026 · NCT02532452A Phase 1/2A, Randomized Study of a T Follicular Helper (TFH)-Targeting Genetic Vaccine Strategy Designed to Induce Broad, Durable Immune Responses
Nagre-recruitPhase 1/2Malugod na tinatanggap ang malusog na boluntaryo
Edad 40 hanggang 64 · Lahat ng kasarian · Na-update Ago 18, 2026 · NCT06810934A Study to Learn About a COVID-19 Vaccine in Healthy Adults 18 Through 64 Years of Age
Nagre-recruitPhase 4Malugod na tinatanggap ang malusog na boluntaryo
Edad 18 hanggang 64 · Lahat ng kasarian · Na-update Ago 7, 2026 · NCT07730450Genetic Studies of Chronic Active Epstein-Barr Disease
Nagre-recruitObservasyonal na pag-aaral
Edad 1 hanggang 120 · Lahat ng kasarian · Na-update Hul 28, 2026 · NCT00032513TETRAVI Multivirus CTL for Treatment of EBV, CMV, Adenovirus, and BK Infections Post Allogeneic SCT.
Nagre-recruitPhase 1
Lahat ng edad · Lahat ng kasarian · Na-update Hun 11, 2026 · NCT04013802Treatment of Refractory BK Infections With Related Donor BK Specific Cytotoxic T-cells (CTLs)
Nagre-recruitPhase 1/2
1 Month – 79 Years · Lahat ng kasarian · Na-update Abr 15, 2026 · NCT04197596A Study to Investigate the Immunogenicity and Safety of mRNA COVID-19 Variant-containing Vaccine Formulations
Nagre-recruitPhase 4Malugod na tinatanggap ang malusog na boluntaryo
6 Months · Lahat ng kasarian · Na-update Mar 27, 2026 · NCT06585241Microbial Cell-free Metagenomic Sequencing for Suspected Infections in Adult Immunocompromised Outpatients
Nagre-recruit
Edad 18 pataas · Lahat ng kasarian · Na-update Ene 30, 2026 · NCT07110636Adoptive T Lymphocyte Administration for Chronic Norovirus Treatment in Immunocompromised Hosts
Nagre-recruitPhase 1
3 Months – 80 Years · Lahat ng kasarian · Na-update Ene 26, 2026 · NCT04691622Mula sa ClinicalTrials.gov, na-kuha noong Okt 5, 2026. Ang bawat pag-aaral ay may sariling pamantayan sa eligibility; ang koponan ng pag-aaral ang magdedesisyon kung sino ang makakasali.